Rituximab Prevents Stroke Recurrences in Atypical Chronic Immune-Mediated Thrombotic Thrombocytopenic Purpura

TH Open. 2018 Dec 5;2(4):e407-e410. doi: 10.1055/s-0038-1676357. eCollection 2018 Oct.

Henry Dupuy¹, Estibaliz Lazaro^{1

2

3}, Irène Machelart¹, Jean-François Viallard^{1

4

5}, Paul Coppo^{6

7

8}, Etienne Rivière^{1

4

5}

¹ Department of Internal Medicine and Infectious Diseases, University Hospital Center of Bordeaux, Haut-Leveque Hospital, Pessac, France.
² ImmunoconcEpT and FHU ACRONIM, UMR CNRS 5164, Bordeaux, France.
³ UMR CNRS 5164, ImmunoconcEpT and FHU ACRONIM, University of Bordeaux, Bordeaux, France.
⁴ Cardiovascular Adaptation to Ischemia, INSERM, Pessac, France.
⁵ Cardiovascular Adaptation to Ischemia, University of Bordeaux, Pessac, France.
⁶ Department of Hematology, Saint-Antoine Hospital, Paris, France.
⁷ Department of Hematology, University Pierre and Marie Curie (UPMC Paris 6), Paris, France.
⁸ French Referral Center for Thrombotic Microangiopathies, APHP, Paris, France.

No abstract available